Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Inovio Pharmaceuticals Net Income 2006-2020 | INO

Inovio Pharmaceuticals net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Inovio Pharmaceuticals Annual Net Income
(Millions of US $)
2019 $-119
2018 $-97
2017 $-88
2016 $-74
2015 $-29
2014 $-36
2013 $-66
2012 $-20
2011 $-15
2010 $-18
2009 $-24
2008 $-13
2007 $-11
2006 $-14
2005 $-26
Inovio Pharmaceuticals Quarterly Net Income
(Millions of US $)
2020-06-30 $-129
2020-03-31 $-33
2019-12-31 $-38
2019-09-30 $-23
2019-06-30 $-29
2019-03-31 $-29
2018-12-31 $-33
2018-09-30 $-25
2018-06-30 $-7
2018-03-31 $-32
2017-12-31 $-22
2017-09-30 $-34
2017-06-30 $-9
2017-03-31 $-23
2016-12-31 $-26
2016-09-30 $-21
2016-06-30 $-19
2016-03-31 $-8
2015-12-31 $-18
2015-09-30 $6
2015-06-30 $-6
2015-03-31 $-11
2014-12-31 $-7
2014-09-30 $-7
2014-06-30 $-11
2014-03-31 $-11
2013-12-31 $-15
2013-09-30 $-31
2013-06-30 $-11
2013-03-31 $-9
2012-12-31 $-1
2012-09-30 $-7
2012-06-30 $-4
2012-03-31 $-8
2011-12-31 $-5
2011-09-30 $-5
2011-06-30 $-3
2011-03-31 $-2
2010-12-31 $-6
2010-09-30 $-1
2010-06-30 $-8
2010-03-31 $-2
2009-12-31 $-7
2009-09-30 $-3
2009-06-30 $-11
2009-03-31 $-3
2008-12-31 $-4
2008-09-30 $-2
2008-06-30 $-4
2008-03-31 $-3
2007-12-31 $-1
2007-09-30 $-3
2007-06-30 $-4
2007-03-31 $-4
2006-12-31 $-8
2006-09-30 $-3
2006-06-30 $-3
2006-03-31
2005-12-31 $-12
2005-09-30 $-3
2005-06-30 $-2
2005-03-31 $-9
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.861B $0.004B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.910B 10.23
Amgen (AMGN) United States $130.879B 14.22
CSL (CSLLY) Australia $94.333B 0.00
Gilead Sciences (GILD) United States $75.236B 10.83
Regeneron Pharmaceuticals (REGN) United States $61.976B 23.70
Vertex Pharmaceuticals (VRTX) United States $55.269B 30.84
Illumina (ILMN) United States $46.974B 54.63
Biogen (BIIB) United States $39.286B 6.98
Seattle Genetics (SGEN) United States $34.263B 0.00
Moderna (MRNA) United States $27.885B 0.00
BeiGene (BGNE) Cayman Islands $27.328B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.301B 10.96
Genmab (GMAB) Denmark $22.905B 14.45
Genmab (GNMSF) Denmark $21.446B 4.94
Exact Sciences (EXAS) United States $19.690B 0.00
Incyte (INCY) United States $19.322B 0.00
BioNTech SE (BNTX) Germany $18.995B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Horizon Therapeutics Public (HZNP) Ireland $16.135B 37.75
Alnylam Pharmaceuticals (ALNY) United States $14.707B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.815B 100.24
ARGENX SE-ADR (ARGX) Netherlands $12.167B 0.00
MyoKardia (MYOK) United States $11.815B 0.00
QIAGEN (QGEN) Netherlands $11.388B 25.64
Guardant Health (GH) United States $11.105B 0.00
Sarepta Therapeutics (SRPT) United States $10.961B 0.00
Bio-Techne Corp (TECH) United States $10.264B 70.42
Mirati Therapeutics (MRTX) United States $9.316B 0.00
Repligen (RGEN) United States $9.232B 146.53
Ascendis Pharma (ASND) Denmark $8.679B 0.00
Galapagos (GLPG) Belgium $8.365B 30.26
ACADIA Pharmaceuticals (ACAD) United States $7.310B 0.00
Adaptive Biotechnologies (ADPT) United States $6.955B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.885B 213.30
Exelixis (EXEL) United States $6.690B 24.33
Acceleron Pharma (XLRN) United States $6.496B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.904B 0.00
Blueprint Medicines (BPMC) United States $5.809B 0.00
Novavax (NVAX) United States $5.490B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.454B 14.90
Arena Pharmaceuticals (ARNA) United States $5.023B 0.00
Emergent Biosolutions (EBS) United States $5.022B 19.89
Amicus Therapeutics (FOLD) United States $4.899B 0.00
Denali Therapeutics (DNLI) United States $4.863B 0.00
China Biologic Products (CBPO) China $4.575B 27.15
NeoGenomics (NEO) United States $4.555B 1375.00
Vir Biotechnology (VIR) United States $4.514B 0.00
Fate Therapeutics (FATE) United States $4.122B 0.00
Halozyme Therapeutics (HALO) United States $4.082B 0.00
Reata Pharmaceuticals (RETA) United States $4.001B 0.00
Twist Bioscience (TWST) United States $3.733B 0.00
Insmed (INSM) United States $3.676B 0.00
Legend Biotech (LEGN) United States $3.605B 0.00
Bluebird Bio (BLUE) United States $3.558B 0.00
Global Blood Therapeutics (GBT) United States $3.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.439B 0.00
MorphoSys AG (MOR) Germany $3.381B 44.31
Eidos Therapeutics (EIDX) United States $2.830B 0.00
Alkermes (ALKS) Ireland $2.530B 53.03
PHARMA MAR SA (PHMMF) Spain $2.396B 0.00
I-Mab (IMAB) China $2.349B 0.00
Seres Therapeutics (MCRB) United States $2.304B 0.00
Editas Medicine (EDIT) United States $2.024B 0.00
Sorrento Therapeutics (SRNE) United States $2.018B 0.00
Beam Therapeutics (BEAM) United States $1.980B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.968B 0.00
Amarin (AMRN) Ireland $1.889B 0.00
Zymeworks (ZYME) Canada $1.885B 0.00
UniQure (QURE) Netherlands $1.875B 0.00
Viela Bio (VIE) United States $1.822B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Revance Therapeutics (RVNC) United States $1.716B 0.00
Intra-Cellular Therapies (ITCI) United States $1.617B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.581B 0.00
Sangamo Therapeutics (SGMO) United States $1.578B 0.00
Intellia Therapeutics (NTLA) United States $1.494B 0.00
Zealand Pharma (ZEAL) Denmark $1.435B 0.00
Ligand Pharmaceuticals (LGND) United States $1.386B 46.84
Arcus Biosciences (RCUS) United States $1.346B 0.00
Epizyme (EPZM) United States $1.315B 0.00
Alcobra (ARCT) United States $1.287B 0.00
Mersana Therapeutics (MRSN) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.274B 7.43
Mesoblast (MESO) Australia $1.265B 0.00
Zealand Pharma (ZLDPF) Denmark $1.264B 0.00
NGM Biopharmaceuticals (NGM) United States $1.200B 0.00
Cytokineticsorporated (CYTK) United States $1.151B 0.00
REGENXBIO (RGNX) United States $1.111B 0.00
Retrophin (RTRX) United States $1.095B 0.00
Myriad Genetics (MYGN) United States $1.079B 0.00
Heska (HSKA) United States $1.060B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.043B 0.00
Genetron Holdings (GTH) China $1.029B 0.00
Castle Biosciences (CSTL) United States $1.009B 0.00
Adverum Biotechnologies (ADVM) United States $0.982B 0.00
Compugen (CGEN) Israel $0.957B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.954B 0.00
Athenex (ATNX) United States $0.930B 0.00
Vericel (VCEL) United States $0.920B 0.00
Northwest Biotherapeutics (NWBO) United States $0.909B 0.00
NantKwest (NK) United States $0.902B 0.00
Scholar Rock Holding (SRRK) United States $0.897B 0.00
Codexis (CDXS) United States $0.851B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.841B 0.00
Morphic Holding (MORF) United States $0.822B 0.00
Arvinas (ARVN) United States $0.806B 0.00
Alector (ALEC) United States $0.789B 0.00
Pliant Therapeutics (PLRX) United States $0.785B 0.00
Intrexon (PGEN) United States $0.767B 0.00
AnaptysBio (ANAB) United States $0.763B 0.00
Frequency Therapeutics (FREQ) United States $0.756B 0.00
Protagonist Therapeutics (PTGX) United States $0.746B 0.00
Cellectis S.A (CLLS) France $0.741B 0.00
Agenus (AGEN) United States $0.704B 0.00
Pharming Group (PHGUF) Netherlands $0.688B 15.71
Syndax Pharmaceuticals (SNDX) United States $0.688B 0.00
MiMedx (MDXG) United States $0.648B 0.00
Cara Therapeutics (CARA) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.622B 0.00
Celldex Therapeutics (CLDX) United States $0.620B 0.00
Kadmon Holdings (KDMN) United States $0.596B 0.00
VBI Vaccines (VBIV) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.579B 5.07
Geron (GERN) United States $0.574B 0.00
IVERIC Bio (ISEE) United States $0.558B 0.00
Cel-Sci (CVM) United States $0.516B 0.00
MeiraGTx Holdings (MGTX) United States $0.510B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.493B 0.00
Albireo Pharma (ALBO) United States $0.489B 0.00
Anika Therapeutics (ANIK) United States $0.489B 21.37
AMAG Pharmaceuticals (AMAG) United States $0.473B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.472B 0.00
UROGEN PHARMA (URGN) United States $0.472B 0.00
Clovis Oncology (CLVS) United States $0.466B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
MannKind (MNKD) United States $0.458B 0.00
Sutro Biopharma (STRO) United States $0.455B 0.00
Avid Bioservices (CDMO) United States $0.443B 0.00
Amryt Pharma (AMYT) United Kingdom $0.441B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.417B 0.00
Starpharma Holdings (SPHRY) Australia $0.411B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Forte Biosciences (FBRX) United States $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.377B 0.00
Cardiff Oncology (CRDF) United States $0.358B 0.00
Cue Biopharma (CUE) United States $0.356B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
AC Immune SA (ACIU) Switzerland $0.354B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.352B 0.00
Kala Pharmaceuticals (KALA) United States $0.352B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.350B 0.00
Spero Therapeutics (SPRO) United States $0.349B 0.00
IBio (IBIO) United States $0.346B 0.00
ANI Pharmaceuticals (ANIP) United States $0.342B 8.08
Kamada (KMDA) Israel $0.339B 16.21
Precision BioSciences (DTIL) United States $0.338B 0.00
Trevena (TRVN) United States $0.334B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.333B 0.00
Innate Pharma S.A (IPHA) France $0.329B 0.00
BioDelivery Sciences (BDSI) United States $0.327B 23.14
Syros Pharmaceuticals (SYRS) United States $0.320B 0.00
Athersys (ATHX) United States $0.320B 0.00
Selecta Biosciences (SELB) United States $0.317B 0.00
CytomX Therapeutics (CTMX) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.287B 0.00
WAVE Life Sciences (WVE) Singapore $0.287B 0.00
NextCure (NXTC) United States $0.284B 0.00
XOMA (XOMA) United States $0.263B 0.00
PDL BioPharma (PDLI) United States $0.254B 0.00
Affimed (AFMD) Germany $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Arbutus Biopharma (ABUS) United States $0.234B 0.00
TELA Bio (TELA) United States $0.233B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.218B 0.00
Fortress Biotech (FBIO) United States $0.214B 0.00
Dyadic (DYAI) United States $0.211B 0.00
Verastem (VSTM) United States $0.210B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
Eton Pharmaceuticals (ETON) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
ADMA Biologics Inc (ADMA) United States $0.184B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.160B 0.00
DBV Technologies S.A (DBVT) France $0.159B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
Kindred Biosciences (KIN) United States $0.155B 0.00
Bellus Health (BLU) Canada $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.147B 0.00
Checkpoint Therapeutics (CKPT) United States $0.146B 0.00
GENFIT S.A (GNFT) France $0.145B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.141B 6.60
Aptinyx (APTX) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Exicure (XCUR) United States $0.138B 0.00
Unum Therapeutics (COGT) United States $0.136B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
SESEN BIO, INC (SESN) United States $0.130B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Cidara Therapeutics (CDTX) United States $0.125B 0.00
Aytu Bioscience (AYTU) United States $0.124B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Strongbridge Biopharma (SBBP) United States $0.108B 0.00
Celyad SA (CYAD) Belgium $0.105B 0.00
Orgenesis (ORGS) United States $0.103B 5.26
Abeona Therapeutics (ABEO) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Enzo Biochem (ENZ) United States $0.092B 0.00
Idera Pharmaceuticals (IDRA) United States $0.090B 0.00
Palatin Technologies (PTN) United States $0.090B 0.00
Cyclerion Therapeutics (CYCN) United States $0.085B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.084B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Evogene (EVGN) Israel $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.079B 75.81
Bionano Genomics (BNGO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Appili Therapeutics (APLIF) Canada $0.061B 0.00
AmpliPhi Biosciences (ARMP) United States $0.059B 0.00
Edesa Biotech (EDSA) Canada $0.058B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Novogen (KZIA) Australia $0.042B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Cleveland BioLabs (CBLI) United States $0.035B 0.00
Apricus Biosciences (SEEL) United States $0.035B 0.00
ATyr Pharma (LIFE) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
OvaScience (MLND) United States $0.029B 0.00
Advaxis (ADXS) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00